Bartels S, et al. – Experts formulated a research to appraise the estrogen receptor (ESR1) mutation in bone metastases from breast cancer. Study findings shed light on an association of ESR1 mutation with estrogen receptor expression and high proliferative activity. In addition, ESR1 mutation influenced about 14% of estrogen receptor–positive bone metastases from breast cancer.